
|Articles|January 1, 2005
CMS to scruntinize Medicare formularies
In evaluating and approving proposals from Medicare prescription drug plans (PDPs), CMS says it will examine a plan's formulary list, pharmacy and therapeutics (P&T) committee operations, and benefit management tools, such as prior authorization and appeals and exceptions policies.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Overlooked bladder nerves now thought to reduce UTI burden through pain signaling, study shows
2
Real-World Usage of Biologics in Psoriatic Arthritis
3
Medicare beneficiaries are paying more for price-negotiated drugs, survey finds
4
Researchers discover new pathway to fight liver inflammation
5





















